EMOGI successfully identified diverse genetic alterations in well-established cancer genes, including APC high mutation frequency in colon cancer, TWIST1 promoter hypermethylation, and MYC copy number amplifications across multiple cancer types. This evidence concerns the gene TWIST1 and cancer.